Key statistics
On Friday, LAVA Therapeutics NV (4PKB:DUS) closed at 1.44, 9.92% above its 52-week low of 1.31, set on Dec 01, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.38 |
---|---|
High | 1.44 |
Low | 1.38 |
Bid | 1.48 |
Offer | 1.64 |
Previous close | 1.43 |
Average volume | 0.00 |
---|---|
Shares outstanding | 26.29m |
Free float | 18.73m |
P/E (TTM) | -- |
Market cap | 38.91m USD |
EPS (TTM) | -0.8976 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 15:00 GMT.
More ▼
Announcements
- LAVA Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
- LAVA Announces Annual Meeting of Shareholders
- LAVA Therapeutics to Participate in the Jefferies Global Healthcare Conference
- LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results
- LAVA Therapeutics to Participate in the Citizens JMP Life Sciences Conference
- LAVA Provides Business Updates and Reports Fourth Quarter and Year-End Financial Results
- LAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052 (formerly SGN-EGFRd2/LAVA-1223)
- LAVA Therapeutics Announces Collaboration with Merck & Co., Inc., Rahway, NJ, USA to Evaluate LAVA-1207 in Combination with KEYTRUDA®
More ▼